BrenneisenLab
banner
brenneisenlab.bsky.social
BrenneisenLab
@brenneisenlab.bsky.social
Biochemist | Professor at Heinrich-Heine-University Düsseldorf, Medical Faculty | interest in #cancer research, #redox biology, metabolism, #nanomedicine | #oxidative #stress | ResearchGate https://bit.ly/3DnqEiU, UKD https://bit.ly/3ZT5kdH
Pinned
Nanoparticles (cerium oxide) and natural compounds such as cardamonin, gossypol or artesunate (often in combination with chemotherapeutics) selectively modulate mitochondrial function and the amount of reactive oxygen species in tumor cells. Have a look on our publications in PubMed bit.ly/3ZWNZR5
Thrilled to share our newest publication in Materials & Design doi.org/10.1016/j.ma...: combinational treatment of the antimalarial drug chloroquine and nanoceria has a selective cytotoxicity on triple negative breast cancer (TNBC) cells in a 2D and 3D cell culture system. To all authors: well done
Redirecting
doi.org
June 9, 2025 at 9:04 PM
Reposted by BrenneisenLab
Reposted by BrenneisenLab
Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk between Apoptosis and Autophagy
aacrjournals.org/mct/article/...
Cannabidiol Induces Programmed Cell Death in Breast Cancer Cells by Coordinating the Cross-talk betw...
Abstract. Cannabidiol (CBD), a major nonpsychoactive constituent of cannabis, is considered an antineoplastic agent on the basis of its in vitro and in vivo activity against tumor cells. However, the ...
aacrjournals.org
October 6, 2023 at 8:22 AM
Wish all followers and members of bluesky 🦋 a Happy New Year and all the best in 2025 🍀🖖
January 2, 2025 at 10:30 AM
Reposted by BrenneisenLab
People with a history of #cancer are less likely to develop #dementia and those with #Alzheimer are less likely to develop cancer. Understanding this relationship, say scientists, could lead to new treatments.
Really enjoyed writing my first piece for The Observer
www.theguardian.com/science/2024...
Are cancer survivors less likely to develop Alzheimer’s?
Research shows that patients with a history of cancer are less likely to develop dementia and those with Alzheimer’s are less likely to develop cancer
www.theguardian.com
November 16, 2024 at 9:20 PM
What is common to almost all tumor types 🤔? A significant increase in the amount of reactive oxygen species (ROS) compared to normal (healthy) cells 👍. Let‘s target that for anticancer therapy? Is that possible? Will see …. .
December 20, 2024 at 6:50 PM
The chalcone cardamonin (CD) has a similar selective effect on tumor cells in context of cell viability as the cerium oxide nanoparticles 😀 - a promising tool for cancer therapy 🤔?
doi.org/10.3390/anti...
doi.org/10.1016/j.ti...
doi.org/10.1371/jour...
December 17, 2024 at 2:56 PM
Cerium oxide nanoparticles (CNP, nanoceria) selectively kill tumor cells without affecting normal (healthy) cells
doi.org/10.1371/jour...
doi.org/10.1371/jour...
doi.org/10.3390/anti...
doi.org/10.1016/j.re...
doi.org/10.1158/1535...
doi.org/10.1089/ars....
doi.org/10.1016/j.bi...
December 17, 2024 at 2:47 PM
Nanoparticles (cerium oxide) and natural compounds such as cardamonin, gossypol or artesunate (often in combination with chemotherapeutics) selectively modulate mitochondrial function and the amount of reactive oxygen species in tumor cells. Have a look on our publications in PubMed bit.ly/3ZWNZR5
December 17, 2024 at 10:16 AM